Buy & Sell UBC Medical Indonesia Tbk. - LABS Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp199.3B | +34.99% |
| Cost of Revenue | Rp119.58B | +32.56% |
| Gross Profit | Rp79.72B | +38.81% |
| General Expenses, Depreciation, Interest | Rp58.24B | +22.15% |
| Operating Profit | Rp21.48B | +120.24% |
| Other Income | -Rp3.96B | -11.3% |
| EBT | Rp17.52B | +231.26% |
| Taxes | -Rp4.02B | +71.79% |
| Net Income | Rp13.51B | +357.5% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp228.19B | +12.08% |
| Total Liabilities | Rp75.72B | +16.78% |
| Total Equity | Rp152.46B | +9.88% |
| Total Liabilities & Total Equity | Rp228.19B | +12.08% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp22.89B | -267.33% |
| CF from Investment | Rp14.25B | +107.84% |
| CF from Financing | Rp10.03B | -116.87% |
| Net Cash Flow | Rp1.39B | -103.57% |